Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Dermira, Inc. (DERM)
|
Add to portfolio |
|
|
|
| Price: |
$5.24
| | Metrics |
| OS: |
54.5
|
M
| |
-1466
|
% ROE
|
| Market cap: |
$286
|
M
| |
-67
|
% ROIC
|
|
Net cash:
|
$77.6
|
M
| |
$1.42
|
per share
|
|
EV:
|
$208
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($203)
|
M
| |
|
|
|
EBIT
|
($204)
|
M
| |
|
|
| EPS |
($4.59)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 42.3 | 4.5 | 22.6 | 7.3 | 7.3 | 0.0 | 0.0 |
| Revenue growth | 832.4% | -79.9% | 209.4% | 0.0% | | | |
| Cost of goods sold | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 41.2 | 4.5 | 22.6 | 7.3 | 7.3 | 0.0 | 0.0 |
| Gross margin | 97.2% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Selling, general and administrative | 172.6 | 71.9 | 30.0 | | | | |
| Research and development | 80.5 | 104.4 | 83.2 | 66.8 | 30.7 | 17.9 | 17.1 |
| General and administrative | | | | 17.7 | 8.3 | 4.4 | 3.1 |
| EBIT | -212.0 | -171.8 | -90.6 | -77.3 | -31.7 | -22.3 | -20.2 |
| EBIT margin | -500.6% | -3782.7% | -401.3% | -1058.2% | -434.2% | | |
| Pre-tax income | -221.7 | -303.3 | -89.1 | -79.0 | -31.8 | -22.4 | -20.3 |
| Income taxes | -0.2 | 0.0 | 0.0 | -0.6 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.1% | 0.0% | 0.0% | 0.8% | | 0.0% | 0.0% |
| Net income | -221.5 | -303.3 | -89.1 | -78.4 | -31.9 | -22.4 | -20.3 |
| Net margin | -523.3% | -6678.3% | -394.4% | -1074.0% | -436.6% | | |
| |
| Diluted EPS | ($5.27) | ($7.48) | ($2.70) | ($2.93) | ($4.96) | ($27.03) | ($27.99) |
| Shares outstanding (diluted) | 42.0 | 40.6 | 33.0 | 26.7 | 6.4 | 0.8 | 0.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|